Ian Shakil - Feb 18, 2023 Form 4 Insider Report for Augmedix, Inc. (AUGX)

Role
CHIEF STRATEGY OFFICER
Signature
/s/ Todd Holvick, Attorney-in-Fact
Stock symbol
AUGX
Transactions as of
Feb 18, 2023
Transactions value $
$0
Form type
4
Date filed
2/22/2023, 08:11 PM
Previous filing
Mar 11, 2022
Next filing
May 25, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUGX Employee Stock Option (right to buy Award $0 +40K $0.00 40K Feb 18, 2023 Common Stock 40K $1.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is granted under the Augmedix, Inc. (the "Issuer") 2020 Equity Incentive Plan. The option will vest monthly in equal increments over four years starting on the grant date, subject to the Reporting Person's provision of service to the Issuer on each vesting date.